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Abstract:  
We introduce a new class of neural implants with the topology and compliance of dura mater, 
the protective membrane of the brain and spinal cord.  These neural interfaces, which we called 
e-dura, achieve chronic bio-integration within the subdural space where they conform to the 
statics and dynamics of neural tissue.  e-dura embeds interconnects, electrodes and chemotrodes 
that sustain millions of mechanical stretch cycles, electrical stimulation pulses, and chemical 
injections.  These integrated modalities enable multiple neuroprosthetic applications.  e-dura 
extracted cortical states in freely behaving animals for brain machine interface, and delivered 
electrochemical spinal neuromodulation that restored locomotion after paralyzing spinal cord 
injury.  e-dura offers a novel platform for chronic multimodal neural interfaces in basic research 
and neuroprosthetics.   
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Neuroprosthetic medicine is improving the lives of countless individuals.  Cochlear implants 
restore hearing in deaf children, deep brain stimulation alleviates Parkinsonian symptoms, and 
spinal cord neuromodulation attenuates chronic neuropathic pain (1).  These interventions rely 
on  implants  developed  in  the  1980s  (2,  3).    Since  then,  advances  in  electroceutical, 
pharmaceutical,  and  more  recently  optogenetic  treatments  triggered  development  of  myriad 
neural  interfaces  that  combine  multiple  modalities  (4-9).    However,  the  conversion  of  these 
sophisticated technologies into chronic implants mediating long-lasting functional benefits has 
yet to be achieved.  A recurring challenge restricting chronic bio-integration is the substantial 
biomechanical mismatch between implants and neural tissues (10-13).  Here, we introduce a new 
class  of  soft  multimodal  neural  interfaces  that  achieve  chronic  bio-integration,  and  we 
demonstrate their long-term efficacy in clinically relevant applications.   
 
e-dura fabrication.  We designed and engineered soft interfaces that mimic the topology and 
mechanical behavior of the dura mater (Fig. 1A-B).  The implant, which we called electronic 
dura mater or e-dura, integrates a transparent silicone substrate (120µm in thickness), stretchable 
gold interconnects (35nm in thickness), soft electrodes coated with a novel platinum-silicone 
composite (300µm in diameter), and a compliant fluidic microchannel (100µm x 50µm in cross-
section)  (Fig.  1C-D,  fig.  S1-S2-S3).    The  interconnects  and  electrodes  transmit  electrical 
excitation  and  transfer  electrophysiological  signals.    The  microfluidic  channel,  termed 
chemotrode (14), delivers drugs locally (Fig. 1C, fig. S3).  Microcracks in the gold interconnects 
(15) and the newly developed soft platinum-silicone composite electrodes confer exceptional 
stretchability  to  the  entire  implant  (Fig.  1B,  Movie  S1).  The  patterning  techniques  of 
metallization and microfluidics support rapid manufacturing of customized neuroprostheses.    4 
e-dura  implantation.    Most  implants  used  experimentally  or  clinically  to  assess  and  treat 
neurological disorders are placed above the dura mater (3, 16-18).  The compliance of e-dura 
enables chronic implantation below the dura mater without extensive durotomy (Fig. 1A-1C, fig. 
S4).  This location provides an intimate interface between electrodes and targeted neural tissues 
(Fig. 1E), and allows direct delivery of drugs into the intrathecal space.  To illustrate these 
properties,  we  fabricated  implants  tailored  to  the  spinal  cord,  one  of  the  most  demanding 
environments of the central nervous system.  We developed a vertebral orthosis to secure the 
connector (Fig. 1F), and dedicated surgical procedures for subdural implantation (fig. S4).  The 
e-dura smoothly integrated the subdural space along the entire extent of lumbosacral segments 
(2.5 cm in length and 0.3 cm in width), conforming to the delicate spinal neural tissue (Fig. 1E-
F). 
 
e-dura bio-integration.  We tested the biocompatibility of the soft e-dura implant compared to a 
stiff implant under chronic conditions (6 weeks).  We fabricated a stiff implant using a 25µm 
thick polyimide film, which corresponds to standard practices for flexible neural implants (19) 
and is robust enough to withstand the surgical procedure.  We inserted both types of implant into 
the subdural space of lumbosacral segments in healthy rats, and prepared sham-operated animals 
that received the headstage, connector, and vertebral orthosis but without spinal implant. 
To assess motor performance, we conducted high-resolution kinematic recordings of whole-body 
movement  during  basic  walking  and  skilled  locomotion  across  a  horizontal  ladder.  In  the 
chronic stages, the behavior of rats with soft implants was indistinguishable from that of sham-
operated  animals  (Fig.  2A,  fig.  S5  and  Movie  S2).    By  contrast,  rats  with  stiff  implants 
displayed  significant  motor  deficits  that  deteriorated  over  time.    They  failed  to  accurately   5 
position their paws onto the rungs of the ladder (Fig. 2A).  Even during basic walking, rats with 
stiff implants showed pronounced gait impairments including altered foot control, reduced leg 
movement, and postural imbalance (fig. S5). 
The spinal cords were explanted after 6 weeks of implantation.  Both soft and stiff implants 
occupied the targeted location  within the subdural  space.  We observed minimal  connective 
tissue around the implants.  To evaluate potential macroscopic damage to spinal cord that may 
explain  motor  deficits,  we  reconstructed  the  explanted  lumbosacral  segments  in  3D,  and 
calculated a cross-sectional circularity index to quantify changes in shape.  All the rats with stiff 
implants displayed significant deformation of spinal segments under the implant (p < 0.001, Fig. 
2B), ranging from moderate to extreme compression (fig. S6, Movie S2).   
We  then  visualized  neuro-inflammatory  responses  at  chronic  stages  using  antibodies  against 
activated astrocytes and microglia (Fig. 2C), two standard cellular markers for foreign body 
reaction (12).  As anticipated from macroscopic damage, both cell types massively accumulated 
in the vicinity of stiff implants (p < 0.05, Fig. 2C, fig. S7).  In striking contrast, we found no 
significant difference between rats with soft implants and sham-operated animals (Fig. 2C, fig. 
S7).  These results demonstrate the chronic biocompatibility of the soft implants.  
 
Bio-integration mechanisms.  We next identified the mechanisms underlying improved bio-
integration of the soft implants.  We manufactured a model of spinal cord using a hydrogel core 
to simulate spinal tissues, and a silicone tube to simulate the dura mater (fig. S8A).  We then 
inserted a soft e-dura implant or a stiff implant into the model (Fig. 2D).  The stiff implant 
induced a pronounced flattening of the simulated spinal cord, while the soft implant did not alter 
the circularity of the model (Fig. 2D, fig. S9).  To provide the model with realistic metrics, we   6 
quantified natural flexure of the spine in freely moving rats (fig. S8B).  When the model was 
bent, the stiff implant formed wrinkles that induced local compressions along the hydrogel core.  
In contrast, the soft implant did not affect the smoothness of simulated spinal tissues (fig. S10).  
When the model was stretched, the stiff implant slid relative to the hydrogel core, whereas the 
soft  implant  elongated  together  with  the  entire  spinal  cord  (Fig.  2D,  fig.  S10).    These 
experimental observations are consistent with theoretical predictions (fig. S9).    
Patterning extremely thin plastic films in web-like systems offers alternative mechanical designs 
for implants conforming to dynamically deforming tissue (20).  However, this type of interfaces 
requires  complex, multi-step processing and transient packaging.  In comparison, fabrication 
steps of e-dura are remarkably simple.  Moreover, the e-dura topology and unusual resilience 
greatly facilitates surgical procedures.  
 
e-dura properties.  We next characterized the electrochemical and electromechanical behavior 
of the platinum-silicone composite electrodes and of the chemotrodes, both in vitro and in vivo.  
The  composite  electrodes  displayed  low  impedance  (Z  =  5.2  ±  0.8  kΩ  at  1  kHz,  n  =  28 
electrodes), and maintained the electrochemical characteristics of platinum (Fig. 3A-B).  Cyclic 
voltammograms  of  the  composite  electrodes  remained  unchanged  when  the  implant  was 
stretched  up  to  a  strain  of  45%.    The  high  effective  surface  area  of  the  platinum-silicone 
composite produced a large cathodal charge storage capacity of 46.9 ± 3.3 mC/cm
2.  This value 
is  two  orders  of  magnitude  higher  than  that  of  smooth  platinum  (21),  and  is  smaller  but 
comparable to that of highly doped organic electrode coatings (22).   
We  then  tested  the  efficacy  of  charge  injection.    The  composite  electrode  supported  charge 
injection limit of 57 ± 9 μC/cm
2, which is comparable to the injection limit of platinum (21) (Fig.   7 
3C, fig. S11).  These characteristics remained stable even after five million electrical pulses, 
which  corresponds  to  more  than  30  hours  of  continuous  stimulation  with  clinically  relevant 
parameters (40Hz, charge-balanced, biphasic, 100μA current pulse, 0.2ms pulse width).   
To demonstrate the robustness of e-dura against deformation experienced by natural dura mater 
during daily living activities, we stretched the device to 20% strain over one million cycles. The 
implant, the chemotrode, and the seven embedded electrodes withstood the cyclic deformation, 
displaying  minimal  variation  in  impedance  over  time  (Fig.  3D,  fig.  S12-S13,  Movie  S1).  
Assuming radical postural changes approximately every 5 minutes, these results indicate that the 
e-dura would survive mechanically for nearly a decade in a patient. 
We  finally  monitored  electrode  impedance  and  chemotrode  functionality  over  time  in  4 
chronically implanted rats (n = 28 electrodes and 4 chemotrodes in total).  Impedance at 1kHz 
remained constant throughout the 5 weeks of evaluation (Fig. 3E), demonstrating stability of 
stretchable  electrodes  in  vivo.    Daily  injections  of  drugs  and  hydrodynamic  evaluations  of 
microfluidic  channels  after  explantation  (fig.  S3)  confirmed  that  the  chemotrodes  remain 
operational for extended durations in vivo.  
These combined results demonstrate electrochemical stability, mechanical robustness, and long-
term  functionality  of  the  e-dura  electrodes  and  chemotrodes,  abiding  the  challenging 
requirements for chronic implantation.  
 
e-dura  applications.    We  next  demonstrated  the  advanced  capabilities  of  e-dura  for  basic 
neuroscience  and  neuroprosthetics.    We  fabricated  an  e-dura  implant  consisting  of  a  3x3 
electrode array, which we placed over the motor cortex of mice expressing channelrhodopsin   8 
ubiquitously  (Fig.  4A).    The  silicone  substrate  is  optically  transparent,  enabling  concurrent 
optical stimulation and neural recording.  To activate neurons, we illuminated the cortical surface 
with a laser focused on distinct locations.  The spatial resolution of electrocorticograms recorded 
from the e-dura allowed extraction of neuronal activation maps that were specific for each site of 
stimulation (Fig. 4A).   
We chronically implanted an e-dura implant between the dura mater and motor cortex tissues 
(fig. S4), and recorded electrocorticograms in conjunction with whole-body kinematic and leg 
muscle activity in freely  moving rats (Fig. 4B).  Power spectral density analysis applied on 
electrocorticograms (23) clearly identified standing and locomotor states over several weeks of 
recordings (Fig. 4B, fig. S14).  To verify whether neural recordings could also be obtained from 
an  e-dura  chronically implanted over spinal  tissues,  we measured  electrospinograms  elicited 
from electrical stimulation of the motor cortex or the sciatic nerve.  Descending motor command 
was reliably recorded (fig. S15), and peripheral sensory feedback was detected with remarkable 
spatial and temporal selectivity after 6 weeks of implantation (Fig. 4C, fig. S15).  
We then exploited the e-dura to restore motor control after spinal cord injury (8, 17).  Adult rats 
received a clinically relevant contusion at the thoracic level, which spared less than 10% of 
spinal tissues at the lesion epicenter, and led to permanent paralysis of both legs (Fig. 4D).  We 
used the chronic spinal e-dura (Fig. 1) to engage spinal locomotor circuits located below injury.  
We injected a serotonergic replacement therapy (5HT1A/7 and 5HT2 agonists) (24) through the 
chemotrode, and delivered continuous electrical stimulation using the soft electrodes located on 
the  lateral  aspect  of  L2  and  S1  segments  (40Hz,  0.2ms,  50-150µA)  (25).    The  concurrent 
electrical  and  chemical  stimulations  instantly  enabled  the  paralyzed  rats  to  walk  (Fig.  4E).  
Intrathecal  delivery  allowed  a  5-fold  reduction  of  injected  drug  volume  compared  to   9 
intraperitoneal injection required to obtain the same facilitation of stepping (fig. S16).  Subdural 
drug  delivery  through  the  chemotrode  annihilated  side  effects  of  serotonergic  agents  on 
autonomic systems (fig. S16).    The distributed electrodes of the e-dura delivered stimulation 
restricted to specific segments, which allowed facilitation of left versus right leg movements (fig. 
S17, Movie S3).  The soft electrochemical neuroprosthesis mediated reliable therapeutic effects 
during the 6-week rehabilitation period.  
 
Conclusions.  We have introduced soft neural implants that are chronically bio-integrated within 
the  central  nervous  system.    We  have  demonstrated  that  biomechanical  coupling  between 
implants and neural tissues is critical to obtain this symbiosis.  The subdural implantation of e-
dura limits foreign body reaction and reduces drug side effects.  This location enables high-
resolution  neuronal  recordings,  and  concurrent  delivery  of  electrical  and  chemical 
neuromodulation  alleviating  neurological  deficits  for  extended  periods  of  time.    Future 
neuroprosthetic  medicine  will  require  chronic,  multimodal,  and  bidirectional  communication 
between implants and neural tissues (1).  e-dura provides a novel platform to design these types 
of  neural  interfaces  integrating  electrodes,  chemotrodes,  and  potentially  optrodes  for  basic 
research and neuroprosthetics.  While challenges lie ahead, e-dura holds promises for a new 
generation of diagnostic and clinical interfaces.   10 
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Figure 1. Electronic dura mater, “e-dura”, tailored for the spinal cord.  (A) Schematic cross-
section of the vertebral column with the soft implant inserted in the spinal subdural space.  (B) 
Strain-stress  curves  of  spinal  tissues,  dura  mater,  implant  materials,  and  complete  e-dura. 
Plastics (polyimide), silicone, e-dura and dura mater responses are experimental data. Spinal 
tissue response is adapted from the literature (see Suppl. data).  (C) Illustration of the e-dura 
implant inserted in the spinal subdural space of rats.  (D) Optical image of an implant, and 
micrographs of the gold film and the platinum-silicone composite.  (E) Cross-section of an e-
dura  inserted  in  the  spinal  subdural  space  during  6  weeks.  (F)  Reconstructed  3D  Micro-
Computed Tomography scans of the e-dura inserted in the spinal subdural space covering L2 to 
S1 spinal segments in rats. The scan was obtained in vivo at week 5 after implantation.     
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Figure 2. e-dura biointegration.  (A) Hindlimb kinematics during ladder walking 6 weeks post-
implantation.  Histogram plots reporting mean percentage of missed steps onto the rungs of the 
ladder (n = 8 trials per rat, n = 4 rats per group).  (B) 3D spinal cord reconstructions, including 
enhanced views, 6 weeks post-implantation.  Bar plots reporting mean values of spinal cord 
circularity index (4π×area/perimeter
2).  (C) Photographs showing microglia (Iba1) and astrocytes 
(GFAP) staining reflecting neuro-inflammation.  Scale bars: 30µm.  Heat maps and bar plots 
showing  normalized  astrocyte  and  microglia  density.    (D)  Spinal  cord  model  scanned  using 
Micro-Computed Tomography without and with a soft or stiff implant.  e-dura implant is 120μm 
thick.  The red line materialized the stiff implant (25μm thick), not visualized due to scanner 
resolution.  Plot reporting local longitudinal strain as a function of global strain. **P < 0.01; *** 
P<0.001.  Error bars: SEM. 
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Figure 3. Properties of e-dura electrodes.  (A) Magnitude and phase of electrode impedance 
recorded in phosphate buffer saline solution (pH 7.4).  Spectra were collected before (■), at 
maximum  elongation  (▼),  and  after  (○)  a  uniaxial  stretch  cycle  to  45%  strain.    Stretch  is 
observed  to  reversibly  affect  the  resistance  of  the  stretchable  interconnect.    (B)  Cyclic 
voltammograms  recorded in  N2  purged, diluted sulfuric acid  (pH 0.9) and during a uniaxial 
stretch cycle to 45% strain.  Slow sweep cyclic voltammetry (50 mV/s) reveals high current 
densities  through  the  electrode  even  at  large  tensile  strain.    The  peaks  correspond  to  oxide 
formation  (*),  oxide  reduction  (**),  H
+  adsorption  (◊◊),  and  H
+  desorption  (◊)  on  Pt  metal 
surfaces.    (C)  Charge  injection  limit  of  electrodes  (n  =  4,  ±  S.D.)  and  evolution  following 
repeated pulse delivery.  (D) Relative impedance modulus of electrodes (n = 7, ± S.D.) recorded 
at  1kHz  and  at  rest  and  following  uni-axial  fatigue  cycling  to  20%  strain.    Inset:  Scanning 
electron micrographs of an electrode after the first and one millionth stretch cycles.  (E) Modulus 
and phase angle of the impedance vector at 1kHz (n = 28 total electrodes, ± S.D, across 4 rats) 
recorded  in  vitro,  then  in  vivo  immediately  after  implantation  and  weekly  until  terminal 
procedure.      15 
 
 
Figure 4.  Recordings and stimulation with e-dura.  (A) e-dura implant positioned over the 
cortical  surface  of  a  Thy1-ChR2-YFP  mouse.    Blue  spot  indicates  laser  location.    Cortical 
activation maps were reconstructed from normalized electrocorticograms, shown in white (150µs 
duration).  (B) Power spectral density computed from motor cortex electrocorticograms recorded 
3 weeks after e-dura implantation in rats.  Increased neural activity in low and high frequency 
bands differentiate cortical states during walking from standing.  (C) Spinal cord activation map 
was  reconstructed  from  electrospinograms  recorded  6  weeks  after  e-dura  implantation  in 
response to left sciatic nerve stimulation.  (D) Rats were chronically implanted with a spinal e-
dura covering lumbosacral segments, and received a severe spinal cord injury.  (E) Recording 
without and with electrochemical stimulation during bipedal locomotion under robotic support 
after 3 weeks of rehabilitation.  Stick diagram decompositions of hindlimb movements are shown 
together with leg muscle activity and hindlimb oscillations. 
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Movie S1: Electronic dura mater.  
This movie illustrates the resilience of the e-dura under various conditions, and shows a 3D 
rendering of a computed tomography scan of the e-dura inserted in the spinal subdural space of a 
rat.   17 
 
Movie S2: e-dura bio-integration.  
This movie shows leg kinematics during locomotion along a horizontal ladder for a sham-
operated rat, a rat implanted with the e-dura and a rat implanted with a stiff implant, and a 3D 
rendering of the reconstructed spinal cords after 6 weeks of implantation.  
 
Movie S3: e-dura applications.  
This movie shows leg kinematics during bipedal locomotion on a treadmill under various 
combinations of chemical and electrical stimulation of lumbosacral segments for a rat that 
received a severe spinal cord injury leading to permanent paralysis.   18 
Table S1: Computed kinematic, ground reaction force, and muscle activity variables. 
 
PARAMETERS  VARIABLE  DETAILED EXPLANATION 
KINEMATICS 
Temporal features     
  1  Cycle duration 
  2  Cycle velocity 
  3  Stance duration 
  4  Swing duration 
  5  Relative stance duration (percent of the cycle duration) 
Limb endpoint (Metatarsal phalange) trajectory     
  6  Interlimb temporal coupling 
  7  Duration of double stance phase 
  8  Stride length 
  9  Step length 
  10  3D limb endpoint path length 
  11  Maximum backward position 
  12  Minimum forward position 
  13  Step height 
  14  Maximum speed during swing 
  15  Relative timing of maximum velocity during swing 
  16  Acceleration at swing onset 
  17  Average endpoint velocity 
  18  Orientation of the velocity vector at swing onset 
  19  Dragging 
  20  Relative dragging duration (percent of swing duration) 
Stability     
Base of support  21  Positioning of the foot at stance onset with respect to the pelvis 
22  Stance width 
Trunk and pelvic 
position and 
oscillations 
23  Maximum hip sagittal position 
24  Minimum hip sagittal position 
25  Amplitude of sagittal hip oscillations 
26  Variability of sagittal crest position 
27  Variability of sagittal crest velocity 
28  Variability of vertical hip movement 
29  Variability of sagittal hip movement 
30  Variability of the 3D hip oscillations 
31  Length of pelvis displacements in the forward direction 
32  Length of pelvis displacements in the medio-lateral direction 
33  Length of pelvis displacements in the vertical direction 
34  Length of pelvis displacements in all directions 
Joint angles and segmental oscillations     
Backward  35  Crest oscillations 
36  Thigh oscillations 
37  Leg oscillations 
38  Foot oscillations 
39  Whole limb oscillations 
Forward  40  Crest oscillations 
41  Thigh oscillations 
42  Leg oscillations 
43  Foot oscillations 
44  Whole limb oscillations 
Flexion  45  Hip joint angle 
46  Knee joint angle 
47  Ankle joint angle 
Abduction  48  Whole limb abduction 
49  Foot abduction 
Extension  50  Hip joint angle 
51  Knee joint angle 
52  Ankle joint angle   19 
Adduction  53  Whole limb adduction 
54  Foot adduction 
Amplitude  55  Crest oscillations 
56  Thigh oscillations 
57  Leg oscillations 
58  Foot oscillations 
59  Whole limb oscillations 
60  Hip joint angle 
61  Knee joint angle 
62  Ankle joint angle 
63  Whole limb medio-lateral oscillations 
64  Foot abduction/adduction 
Velocity     
Minimum  65  Whole limb oscillation velocity 
66  Hip joint angle velocity 
67  Knee joint angle velocity 
68  Ankle joint angle velocity 
Maximum  69  Whole limb oscillation velocity 
70  Hip joint angle velocity 
71  Knee joint angle velocity 
72  Ankle joint angle velocity 
Amplitude  73  Whole limb angle velocity 
74  Hip joint angle velocity 
75  Knee joint angle velocity 
76  Ankle joint angle velocity 
Inter-limb coordination     
PC analysis  77  Degree of linear coupling between joint oscillations 
FFT 
decomposition 
78  Temporal coupling between crest and thigh oscillations 
79  Temporal coupling between thigh and leg oscillations 
80  Temporal coupling between leg and foot oscillations 
81  Correlation between crest and tight oscillations 
82  Correlation between tight and leg oscillations 
83  Correlation between leg and foot oscillations 
Cross-correlation  84  Correlation between hip and knee oscillations 
85  Correlation between knee and ankle oscillations 
86  Correlation between ankle and MTP oscillations 
87  Temporal lag between backward positions of crest and thigh oscillations 
88  Temporal lag between forward positions of crest and thigh oscillations 
Relative coupling  89  Temporal lag between backward positions of thigh and leg oscillations 
90  Temporal lag between forward  positions of the thigh and leg oscillations 
91  Temporal lag between backward positions of leg and foot oscillations 
92  Temporal lag between forward positions of leg and foot oscillations 
Inter-segmental 
coordination 
compared to 
Able-bodied rats 
93  Lag of the cross correlation function between hindlimb oscillations 
94  Maximum R-value of the cross correlation function between hindlimb 
oscillations 
95  Lag of the cross correlation function between hip oscillations 
96  Maximum R-value of the cross correlation function between hip 
oscillations 
97  Lag of the cross correlation function between knee oscillations 
98  Maximum R-value of the cross correlation function between knee 
oscillations 
99  Lag of the cross correlation function between ankle oscillations 
100  Maximum R-value of the cross correlation function between ankle 
oscillations 
101  Lag of the cross correlation function between endpoint oscillations 
102  Maximum R-value of the cross correlation function between endpoint 
oscillations 
103  Phase of the first harmonic of the FFT of the hip elevation angle 
104  Amplitude of the first harmonic of the FFT of the hip elevation angle   20 
105  Phase of the first harmonic of the FFT of the knee elevation angle 
106  Amplitude of the first harmonic of the FFT of the knee elevation angle 
107  Phase of the first harmonic of the FFT of the ankle elevation angle 
108  Amplitude of the first harmonic of the FFT of the ankle elevation angle 
Left–right 
hindlimb 
coordination 
109  Phase of the first harmonic of the FFT of the endpoint elevation angle 
110  Amplitude of the first harmonic of the FFT of the endpoint elevation angle 
111  Phase of the first harmonic of the FFT of the hindlimb elevation angle 
112  Amplitude of the first harmonic of the FFT of the hindlimb elevation angle 
113  Lag of the cross correlation function between crest and thigh limb 
elevation angles 
Hindlimb  
coordination 
114  Lag of the cross correlation function between thigh and hindlimb 
elevation angles 
115  Lag of the cross correlation function between hip and thigh elevation 
angles 
116  Lag of the cross correlation function between hindlimb and foot elevation 
angles 
117  Lag of the cross correlation function between thigh and ankle elevation 
angles 
118  Lag of the cross correlation function between ankle and foot elevation 
angles 
KINETICS 
  119  Medio-lateral forces 
  120  Anteroposterior forces 
  121  Vertical forces 
  122  Weight-bearing level 
MUSCLE ACTIVITY 
Timing (relative to cycle duration, paw contact to paw contact)     
Extensor  
 
123  Relative onset of ipsilateral extensor muscle activity burst 
124  Relative end of ipsilateral extensor muscle activity burst 
Flexor 
 
125  Relative onset of ipsilateral flexor muscle activity burst 
126  Relative end of ipsilateral flexor muscle activity burst 
Duration     
Extensor   127  Duration of ipsilateral extensor muscle activity burst 
Flexor   128  Duration of ipsilateral flexor muscle activity burst 
Amplitude     
Extensor   129  Mean amplitude of ipsilateral muscle activity burst 
  130  Integral of ipsilateral extensor muscle activity burst 
  131  Root mean square of ipsilateral extensor muscle activity burst 
Flexor  132  Mean amplitude of ipsilateral flexor muscle activity burst 
  133  Integral of ipsilateral flexor muscle activity burst 
  134  Root mean square of ipsilateral flexor muscle activity burst 
Muscle coactivation  135  Co-contraction of flexor and extensor muscle 
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Figure S1. Soft neurotechnology for e-dura implants.  The process flow, illustrated in cross-
sectional views, consists of 6 main steps.  (1) Elastomeric substrate and stretchable interconnects 
fabrication.  Patterning (2) and bonding (3) of interconnects’ passivation layer.  (4) Coating of 
the electrodes with a customized platinum-silicone composite screen-printed above the electrode 
sites.  (5) Integration of the PDMS microfluidic channel and connector. (6) Release of the e-dura 
implant in water.   
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Figure S2.  Mechanical characterization of the platinum-silicone composite.  (A) To estimate 
the elastic modulus of the coating composite, we fabricated a high aspect ratio pillar with a 
rectangular cross-section (L = 3 mm, h= 113 µm, w=480 µm, 4:1 w:w Pt:PDMS composite).  
The pillar was then mounted vertically.  (B) To obtain a force-displacement curve, we measured 
the force required to deflect the free end of the pillar by a small distance Δx.  We used a linear fit 
to the loading portion of the force-displacement curve and bending beam theory to derive the 
Young’s Modulus (E) of the composite.  In this equation, I is the moment of inertia defined by 
the known cross-section dimensions of the beam, E is the elastic modulus of the beam, and Fx is 
the force needed to produce a displacement Δx.  We found the elastic modulus of the platinum-
silicone composite was approximately 10 MPa.  
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Figure S3.  e-dura chemotrode: compliant fluidic microchannel.  (A) Determination of the 
hydrodynamic resistance of the microfluidic system.  The continuous line displays the fluid flow 
predicted  by  the  Poiseuille-Hagen  equation.    Monitoring  the  hydrodynamic  response  of  the 
chemotrode before surgery and after explantation following 6 weeks of chronic implantation 
demonstrated that the microfluidic channels do not become occluded with tissue or debris, and 
maintain  functionality  during  prolonged  subdural  implantation.    (B)  Blue-colored  water  was 
injected  through  the  chemotrode  under  different  tensile  conditions.  The  integrity  and 
functionality of the microfluidic channel was maintained when the implants was stretched up to a 
strain of 40%. 
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Figure S4.  Orthoses and surgical procedures for chronic e-dura implantation.  (A-B) Spinal 
e-dura.    (A)  Surgical  procedure  to  slide  the  e-dura  below  the  dura  mater  covering  lumbar 
segments.  (B) Side view of the engineered vertebral orthosis that secures the e-dura connector, 
and ensures long-term functionality of embedded electrodes and chemotrode in vivo.  (C-D) 
Cortical e-dura. (C) Surgical procedure to slide the e-dura below the dura mater covering the 
motor cortex.  (D) Side view describing the engineered cortical orthosis that secures the e-dura 
and its connector, ensuring chronic recordings of electrocorticograms in freely moving rats. 
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Figure S5.  Kinematic analysis of gait patterns during basic overground locomotion. (A) 
Representative stick diagram decomposition of hindlimb movement during two successive gait 
cycles performed along a horizontal unobstructed runway.  Recordings were obtained 6 weeks 
after surgery for a sham-implant rat, and for a rat implanted with an e-dura or a stiff implant, 
from left to right.  (B) A total of 135 parameters providing comprehensive gait quantification 
(Table  S1)  were  computed  from  high-resolution  kinematic  recordings.    All  the  parameters 
computed for a minimum of 8 gait cycles per rat at 6 weeks post-implantation were subjected to 
a principal component (PC) analysis.  All gait cycles (n = 102, individual dots) from all tested 
rats (n = 4 per group) are represented in the new 3D space created by PC1-3, which explained 
40% of the total data variance.  This analysis revealed that sham-operated rats and rats with e-
dura exhibited similar gait patterns, whereas rats with stiff implants showed markedly different 
gait  characteristics  compared  to  both  other  groups.    (C)  To  identify  the  specific  features 
underlying these differences, we extracted the parameters with high factor loadings on PC1, and 
regrouped them into functional clusters (not shown), which we named for clarity.  This analysis 
revealed that rats with stiff implants displayed impaired foot control, reduced amplitude of leg 
movement, and postural imbalance.  To illustrate these deficits using more classic parameters, 
we generated plots reporting mean values of variables with high factor loadings for each of the 3 
identified functional clusters.  ***, P < 0.001. ****, P < 0.0001. ns, non-significant. Error bars: 
S.E.M. 
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Figure  S6.  Damage  of  spinal  tissues  after  chronic  implantation  of  stiff,  but  not  soft, 
implants.  3D reconstructions of lumbosacral segments for all 16 tested rats (3 groups of 4 
animals), including enhanced views.  The spinal cords were explanted and reconstructed through 
serial Nissl-stained cross-sections after 6-week implantation.  Stiff implants induced dramatic 
damage of neural tissues, whereas the e-dura had a negligible impact on the macroscopic shape 
of the spinal cord. 
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Figure S7. Significant neuro-inflammatory responses after chronic implantation of stiff, 
but  not  soft,  implants.    Cross-section  of  the  L5  lumbar  segment  stained  for  the  neuro-
inflammatory markers GFAP (astrocytes) and Iba1 (microglia) after 6-week implantation.  A 
representative photograph is shown for each group of rats.  The stiff implant leads to a dramatic 
increase in the density of neuro-inflammatory cells, whereas the e-dura had a negligible impact 
on these responses. Scale bars, 500µm.   
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Figure  S8.  Model  of  spinal  cord  and  experimental  quantification  of  vertebral  column 
curvatures in freely behaving rats.  (A) The mechanical model of spinal cord is composed of a 
hydrogel that simulates spinal tissue, and a silicone membrane that simulates the dura mater.  
The soft or stiff implant was inserted between the hydrogel and the silicone membrane.  The 
water trapped under the simulated dura mater ensured constant lubrication of the entire implant.  
Both ends of the model were sealed with silicone forming the clamping pads used in stretching 
experiments.  (B) To measure the range of physiologically relevant vertebral column curvatures, 
we recorded spontaneous movement of a healthy rat during exploration of a novel environment. 
Reflective markers were attached overlying bony landmarks to measure motion of the vertebral 
column.  The photographs displayed the stereotypical motor behaviors that were extracted for 
further analysis.  For each behavior, we fitted a polynomial function through the inter-connected 
chain of markers.  The resulting curvatures are reported along the x-axis.  Since the markers were 
attached to the moving skin, the radii of curvature experienced by the vertebral column, and even 
more by the spinal cord itself, are expected to be at least 1 to 2mm smaller.  We used the 
measured radii of curvature to define the bending limits applied to the spinal cord-implant model 
tested under flexion.  
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Figure S9.  Mechanical effects of implants on the model of spinal cord.  (A) Ratios of the 
mechanical  properties  of  the  materials  used  to  prepare  the  soft  (i.e.  silicone)  and  stiff  (i.e. 
polyimide) implants.  Bending stiffness describes the resistance of the implant towards flexion, 
while tensile stiffness refers to the resistance of the implant towards elongation.  Although the 
stiff implant is five times  thinner than the soft implant, its  tensile and flexural  stiffness are 
respectively two and one orders of magnitude larger.  (B) Micro-Computed Tomography (μCT) 
images and Finite Element (FE) Simulation strain maps of the cross-sections of the model of 
spinal cord carrying a soft or a stiff implant.  No external deformation is applied to the model.  
The 25µm thick polyimide implant is highlighted with a dotted red line because the resolution of 
the μCT is not high enough to distinguish the thin plastic film. The FE simulations depict the 
maximum logarithmic strain inside the model of spinal cord computed with the geometry and 
materials properties of the spinal cord models and implants.  (C) Schematic longitudinal cross-
section of the model of spinal cord model carrying a stiff implant.  The model system is stretched 
along the length of the implant by 20% strain.  The high tensile stiffness Sstiff = Estiff . tstiff of the 
implant compared to  that  of the  simulated  spinal  cord leads  to  nearly  unstretched  simulated 
spinal tissues immediately underneath the implant and highly deformed spinal tissues away from 
the implant. 
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Figure S10.  Effect of tensile deformations on the implants and on the model of spinal cord.  
(A) To measure local strains, we tracked fiducial markers in the hydrogel ‘spinal tissue’ and on 
the soft or stiff implant.  Graphite powder particles were mixed with the hydrogel during gel 
preparation.  Parallel lines with 1mm inter-distance were drawn directly onto the surface of the 
implants.  The model was flexed to controlled bending radii, which covered the entire range of 
physiologically  relevant  spinal  movement  determined  in  vivo  (fig.  S8).    The  soft  implant 
conformed to the flexion of simulated spinal tissues.  The strain along the sagittal crest of the 
model  (broken  line)  was  determined  experimentally  (discrete  symbols)  and  compared  to  a 
geometrical prediction (continuous line).  The stiff implant started wrinkling with radii smaller 
than 30mm.  The amplitude of wrinkles, termed A, and the wavelength depended on the bending 
radius.  (B) The spinal cord - implant model was placed under uniaxial (global) tensile stretch.  
Local strain was measured by tracking the displacement of pairs of particles in the gel (n=8 
pairs), or neighboring stripes on the implants (n=10 pairs).  The graphs quantify locally induced 
strain in the implant and in the hydrogel core (spinal tissues) as a function of the global applied 
strain to the model.  The soft implant stretched with the model of spinal cord.  In contrast, there 
was  a  substantial  mismatch  between  the  local  strain  inside  the  model  and  the  induced 
deformation of the stiff implant.  Consequently, the stiff implant slid between the silicone and 
the hydrogel during stretch.      31 
 
 
 
Figure S11.  Determination of charge injection capacity of electrodes with platinum-silicone 
coating.    (A)  Charge-balanced,  biphasic  current  pulses  were  injected  through  electrodes 
immersed in saline electrolyte (PBS).  The duration of each pulse phase was fixed at 200μs per 
phase, which corresponds to the typical pulse duration used during therapeutic applications.  (B) 
The amplitude of the current pulses was gradually increased.  As the current density flowing 
through the coating and its polarization increased, a significant portion of the recorded voltage 
drop occurred in the electrode interconnects and the electrolyte above the coating.  (C) To obtain 
the true voltage transients at the coating surface with respect to the reference electrode, the 
instantaneous polarization of the cell was subtracted.  The maximum safe current density was 
reached when the coating polarization exited the water window.  
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Figure S12. Impedance spectroscopy of the soft electrodes under cyclic stretching to 20% 
strain.  (A) Apparatus for conducting electrochemical characterization of soft implants under 
tensile strain.  The ends of the implant were glued to two probes that are clamped to the jaws of a 
custom  built  extensimeter.    The  implant  and  (partially)  the  probes  were  then  submerged  in 
Phosphate  Buffered  Saline  (PBS).    The  extensimeter  applied  pre-defined  static  strain  to  the 
implant, or performed a cyclic stretch-relax program. A counter and a reference electrode were 
submerged in the electrolyte to complete the circuit (not shown).  (B) Representative impedance 
plots recorded from one electrode.  The spectra were recorded at 0% applied strain after 10, 
1’000, 10’000, 100’000 and 1 million stretch cycles.  Each stretch cycle lasted 1s.  The implants 
remained immersed in PBS throughout the evaluations.  The remaining 6 electrodes in the tested 
implants exhibited a similar behavior.  
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Figure  S13.    In-situ  scanning  electron  micrographs  of  platinum-silicone  coatings.  (A) 
Images collected during the first stretch cycle to 20% applied strain (from pristine electrode).  
Low magnification scanning electron micrographs taken at 20% strain revealed the appearance 
of cracks, but the absence of delamination.  The high effective surface area of the composite 
coating is clearly visible in medium magnification scanning electron micrographs (lower panels).  
(B) Images collected before (cycle 0) and after one million stretch cycles to 20% strain.  All the 
images were taken at 0% strain.  High-magnification scanning electron micrographs revealed the 
effects of fatigue cycling on the nano-scale morphology of the composite coating. 
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Figure S14.  Motor cortex electrocorticograms reflecting motor states in freely moving rats.  
(A) Raw color-coded voltage recorded against the common average for each electrode of the 
chronically implanted e-dura.  Colors correspond to motor states, which were identified from 
kinematic  and  muscle  activity  recordings  (not  shown),  and  labeled  as  continuous  walking 
(black),  transition  from  walking  to  standing  (grey),  and  standing  (red).    (B)  Each 
electrocorticogram was Fourier transformed into time resolved power spectral density estimates 
(trPSD), shown in units of standard deviation (std).  (C) Mean trPSD obtained by averaging 
trPSDs  across  all  the  electrodes.    Each  trPSD  was  normalized  to  average  trPSD  in  each 
frequency in order to account for drop in power with increasing frequencies.  The transparent 
regions corresponds to the frequency sub-bands that were excluded from the analysis to remove 
the effect of the 50Hz line noise and its higher order harmonics.  (D) The electrode-averaged 
trPSD  estimates  were  integrated  across  all  possible  continuous  frequency  bands  in  order  to 
calculate the power of electrocorticograms. The plot reports the mean values (+/- SEM) of the 
power spectral density for standing and walking states. The shared areas indicate the limits of 
low (LFB) and high (HFB) frequency bands, which were identified based on the local minima of 
p values (Wilcoxon rank-sum).  Histogram plots report the mean values (+ SEM) of electrode-
averaged power in the identified bands. ***, p < 0.001. (E) Electrode-averaged trPSD, identified 
low and high frequency bands, and histogram plots reporting means values (+SEM) of power   35 
differences in each identified bands between walking and standing states, are shown for each rat 
(n = 3 rats in total).  Elevated power in low and high frequency bands during walking compared 
to standing is consistent with electrocorticogram recordings during hand movements in humans 
(23).      36 
 
Figure  S15.  Recordings  of  electrospinograms  following  peripheral  nerve  and  brain 
stimulation.  An e-dura was chronically implanted over lumbosacral segments for 6 weeks in 3 
rats.  Terminal experiments were performed under urethane anesthesia.  (A) Electrospinograms 
and left medial gastrocnemius muscle activity were recorded in response to electrical stimulation 
of the left sciatic nerve.  (B) Representative color-coded electrospinograms and muscle activity 
responses are displayed for increasing stimulation intensities.  Electrospinograms appeared at 
lower  threshold  than  muscle  responses,  suggesting  that  e-dura  electrodes  measured  neural 
activity related to the recruitment of myelinated fibers.  (C) Bar plot reporting mean values (10 
trials per rat) of electrospinogram amplitudes for left versus right side electrodes.  Responses 
were significantly larger on the stimulation side (t-test, p<0.001).  (D) Correlation plot showing 
the relationship between electrode location and the latency of electrospinogram responses.  The 
locations  are  referred  to  the  left  L2  electrode,  which  is  the  closest  to  sciatic  nerve  afferent 
neurons. The measured neural conduction velocity from lumbar to sacral segments, which was 
derived from the correlation line, is coherent with the conduction velocity of large-myelinated 
fibers.  (E) Power spectrum of electrospinograms is condensed in the region below 1000Hz, 
which is consistent with a lead field potential signal, most likely arising from the afferent volley 
and related synaptic events. These combined results demonstrate the high degree of spatial and 
temporal selectivity in the neural recordings obtained with e-dura.  (F) A stimulating electrode 
was positioned over the motor cortex of the same rats (n = 3) to elicit a descending volley. (G) 
Representative color-coded recording of an electrospinogram and muscle activity following a 
single pulse of motor cortex stimulation.  (H) Bar plot reporting the mean (10 trials per rat) 
latency (+ SEM) of electrospinograms and muscle activity responses following a single pulse of 
stimulation.    Electrospinograms  systematically  preceded  muscle  evoked  responses  (t-test   37 
p<0.001).  (I) The power spectrum of electrospinograms was condensed in the region below 
1,000Hz, which was consistent with a neural response related to multiple descending pathways.      38 
 
Figure S16.  Drug delivery through the chemotrode annihilates side effects. (A) Rats (n = 3) 
were  tested  during  bipedal  locomotion  under  robotic  support  after  1  week  of  rehabilitation. 
Recordings  were  performed  without  stimulation,  and  with  concurrent  electrochemical 
stimulation. Chemical stimulation was delivered either intrathecally through the chemotrode, or 
intraperitonaelly. The drug volumes were adjusted to obtain the same quality of stepping. Color-
coded stick diagram decompositions of hindlimb movements are shown together with muscle 
activity of antagonist ankle muscles. (B) Bar plots reporting mean values of drug volumes to 
obtain optimal facilitation of locomotion for each serotonergic agonist. (C) Bar plots reporting 
the  effects  of  optimal  drug  volumes  on  autonomic  functions.  Salivation  and  micturition  are 
reported  using  a  visual  scaling  system  ranging  from  0  (baseline,  no  drug)  to  5  (maximum 
possible effects).  *, P < 0.05. **, P < 0.01. ***, P < 0.001. Error bars: S.E.M. 
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Figure S17.  The electrochemical neuroprosthesis e-dura mediates specific adjustments of 
locomotion.  (A) Spinal cord injured rats (n = 3) were recorded during bipedal locomotion on a 
treadmill after 3 weeks of rehabilitation.  The rats were tested without stimulation (spontaneous) 
and  during  various  combinations  of  chemical  and/or  electrical  lumbosacral  stimulations,  as 
explained at the top and bottom of each panel.  For each condition, a color-coded stick diagram 
decomposition of left and right hindlimb movements is displayed together with left and right 
muscle  activity,  and  the  color-coded  duration  of  stance,  swing,  and  drag  phases.  Without   40 
stimulation, both legs dragged along the treadmill belt.  Electrical stimulation alone delivered at 
the level of lumbar (L2) and sacral (S1) electrodes, but only on the left side, induced rhythmic 
movement restricted to the left leg.  Chemical stimulation alone, composed of 5HT1A/7 and 5HT2 
agonists, did not induce locomotion, but raised the level of tonic muscle activity in both legs.  
After  chemical  injection,  delivery  of  electrical  stimulation  on  the  left  side  induced  robust 
locomotor  movements  restricted  to  the  left  leg.    The  combination  of  chemical  and  bilateral 
electrical stimulation promoted coordinated locomotor movements with weight bearing, plantar 
placement,  and  alternation  of  left  and  right  leg  oscillations.  (B)  A  total  of  135  parameters 
providing comprehensive gait quantification (Table S1) was computed from kinematic, kinetic, 
and muscle activity recordings.  All the parameters were subjected to a PC analysis, as described 
in fig. S5.  All the gait cycles (n = 226, individual dots) from all the tested rats (n = 3) and 3 
healthy rats are represented in the new 3D space created by PC1-3, which explained nearly 50% 
of the total data variance.  The inset shows elliptic fitting applied on 3D clusters to emphasize the 
differences  between  experimental  conditions.    The  bar  plot  reports  locomotor  performance, 
which was quantified as the mean values of scores on PC1 (8). This analysis illustrates the 
graded improvement of locomotor performance under the progressive combination of chemical 
and  bilateral  electrical  stimulation.    (C)  To  identify  the  specific  features  modulated  with 
chemical and electrical stimulation, we extracted the parameters correlating with PC1 (factor 
loadings), and regrouped them into functional clusters, which we named for clarity. The numbers 
refer to variables described in Table S1.  (D) Bar plots reporting mean values of variables with 
high factor loadings, for each of the 5 functional clusters, as highlighted in panel C. *, P < 0.01. 
***, P < 0.0001. Error bars: S.E.M.   41 
Materials and Methods  
Soft e-dura materials and fabrication process 
We designed and fabricated brain and spinal e-dura implants using soft neurotechnology.  The 
spinal implant hosts seven electrodes, distributed along the length of the implant in a 3-1-3 
configuration array, and a  microfluidic delivery system (single channel).  The brain  implant 
consists of electrodes, patterned in a 3x3 matrix.  A generic fabrication process is presented fig. 
S1.  The fabrication steps of the three components integrated in e-dura implants are detailed 
below. 
 
Interconnects (fig. S1-1) 
i)  First a 100μm thick substrate of polydimethylsiloxane (PDMS, Sylgard 184, Dow Corning, 
mixed at 10:1, w:w, pre-polymer:cross-linker) was spin-coated on a 3” silicon carrier wafer 
pre-coated with polystyrene sulfonic acid (water soluble release layer).  The PDMS substrate 
was then cured overnight in a convection oven (80°C). 
ii)  Then a customized Kapton
© shadow mask patterned with the negative of the electrode layout 
was laminated on the PDMS substrate.  Thermal evaporation of 5/35nm of chromium/gold 
(Cr/Au) metal films through the shadow mask deposited the interconnect tracks (Auto 360, 
Edwards).   
 
Electrical passivation layer (fig. S1-2) 
i)  The interconnect passivation layer was prepared in parallel.  A 5” wafer sized, 5mm thick 
slab  of  PDMS  was  produced  and  its  surface  was  functionalized  with  a  1H,1H,2H,2H-  42 
perfluorooctyltriethoxysilane (Sigma-Aldrich) release monolayer under weak vacuum. Two 
thin PDMS layers of 20μm thickness were sequentially spin-coated on the thick PDMS slab, 
individually cured then treated with the debonding monolayer.  In cross-section, the structure 
was a triple stack consisting of a thick PDMS slab and two thin PDMS layers.  The release 
coatings allowed for each of the 20μm thick layers to be peeled off independently at a later 
stage.  
ii)  Using a hollow glass capillary of a pre-defined tip diameter, both 20μm thick PDMS layers 
were simultaneously punctured at locations corresponding to the sites of the electrodes.  
 
Encapsulation (fig. S1-3) 
i)  Both PDMS triple stack and interconnect wafers were exposed to brief air plasma activating 
the silicone surfaces.  The triple stack was flipped upside down to align the punctured holes 
with the underlying electrodes.  
ii)  The two pieces were brought together to form a covalent bond.  The thick PDMS slab was 
peeled off, leaving behind the two 20μm thick PDMS layers on top of the interconnects.  
 
Soft platinum-silicone composite preparation and patterning (fig. S1-4) 
i)  e-dura electrode sites were coated with a customized platinum-silicone composite.  The 
conductive composite was a blend of platinum nano-micro particles and PDMS (Sylgard 
184, Dow Corning).  The PDMS pre-polymer, mixed with its cross-linker, was diluted in 
heptane in a 1:2 w:w ratio to create a low viscosity liquid.  In a small container, 100mg of 
platinum microparticles (Pt powder, particle size 0.5-1.2μm, Sigma-Aldrich) was added to 
5mg of PDMS (20μL of heptane diluted PDMS).  This mixture was thoroughly stirred and   43 
put aside for evaporation of the heptane fraction.  The addition of 5mg doses of PDMS was 
repeated  until  the  mixture  (after  heptane  evaporation)  became  a  paste.    Paste  formation 
occurs when the PDMS content is 15-20% by weight.  Immediately before dispensing onto 
the electrode sites, the paste may be thinned with a drop of pure heptane. 
ii)  To form the active electrode coating, a bolus of conductive composite paste was “printed” 
i.e. spread and pressed into the holes of the upper encapsulation layer.  
iii)  The upper encapsulation layer was then peeled off, leaving bumps of conductive composite 
precisely  at  the  active  electrode  sites.    The  bottom  20μm  thick  PDMS  layer  remained 
permanently  bonded  to  the  electrode-interconnect  e-dura  substrate,  thereby  providing 
electrical encapsulation.  The array was placed in a convection oven at 60°C overnight to 
ensure full polymerization of the conductive paste. 
 
Microfluidic and connector integration (fig. S1-5) 
i)  To form the microfluidic delivery system, an additional 80μm thick PDMS layer was bonded 
to the metallized e-dura substrate.  This layer covered approximately a third of the length of 
the  implant  and  contained  a  central  microfluidic  channel  (100x50μm
2  in  cross  section), 
terminating 2 mm caudally from the 3 caudal electrodes (Movie S1).  The connector side of 
the  microchannel  was  interfaced  with  a  polyethylene  capillary  (0.008”  i.d.,  0.014”  o.d., 
Strategic Applications Inc.) and sealed with a bolus of fast-cure silicone (KWIK-SIL, World 
Precision Instruments).  
ii)  A custom-made soft-to-wires electrical connector was assembled for all the e-dura implants.  
De-insulated ends of ‘Cooner’ wires (multistranded steel insulated wire, 300μm o.d., Cooner 
wire Inc.) were carefully positioned above the terminal pads of the gold film interconnects.    44 
The electrical contact  was  enhanced by ‘soldering’ the wires  to  the contact  pads  with  a 
conductive polymer paste (H27D, component A, EPO-TEK) deposited below and around 
each electrical wire.  To stabilize the connector, the ‘solder’ connection area was flooded 
with  a  silicone  adhesive  to  form  a  package  (One  component  silicone  sealant  734,  Dow 
Corning) (Fig. 1D). 
 
Release (fig. S1-6) 
i)  The contour of the finished implant was cut out from the wafer using a razor blade.  The 
implant was released from the carrier wafer upon a brief immersion in water.  
 
Description of the implants prepared for the biocompatibility study  
For the purpose of the biocompatibility study, we designed and fabricated soft e-dura and stiff 
implants.  Four copies of each type were fabricated and implanted chronically in the subdural 
space of the lumbosacral spinal cord in healthy rats. 
 
e-dura implants 
The e-dura were functional silicone implants, including both the microfluidic channel and seven 
electrodes, and were designed to fit the intrathecal space of the spinal cord.  The implants were 
prepared following the process presented above.  
 
Stiff implants  
Stiff implants were cut out from 25μm thick polyimide foil (KaptonTM-100HN, DuPont).  The 
intraspinal dwelling portion of these devices was 3.2mm wide and 3cm long.  The contour of the   45 
implant was cut out using a laser micromachining tool (LAB 3550, Inno6 Inc.) and had rounded 
edges to minimize tissue trauma during insertion.  At its caudal end, the implant integrated the 
same trans-spinal electrical connector as the one used in the soft implants. However, neither 
electrodes nor interconnects were patterned on the polyimide foil.  The dummy connector was 
8mm long, 11mm wide and 2mm thick and coupled seven insulated wires (multistranded steel 
insulated  wire,  300μm  o.d.,  Cooner  wire  Inc.)  that  run  sub-cutaneous  away  from  the  spinal 
orthosis to a head mounted socket (12 pin male micro-circular connector, Omnetics corp.). 
 
Sham-operated rats  
Sham-operated rats received an implant without intraspinal portion.  The implant consisted of the 
same connector as that used in the other two types of implants, which was secured with the 
spinal orthosis, and then attached to seven wires running subcutaneously, and terminating in a 
head-mounted Omnetics connector. 
 
Mechanical spinal cord model (fig. S8A) 
We assembled a spinal cord model to simulate the mechanical interaction between spinal tissue 
and soft versus stiff implants after their positioning on the spinal tissue and during dynamic 
movement of the spinal cord.  Artificial dura mater and spinal tissues were fabricated from 
PDMS and gelatin hydrogel, respectively (26, 27).  One end of a polystyrene rod (20cm long, 
3.2mm diameter) was attached to the drive shaft of a mixer.  The mixer was positioned so that 
the rod was horizontal and rotating about its long axis, approximately a centimeter above the 
surface of a hotplate. Several grams of freshly prepared PDMS pre-polymer (Sylgard 184, Dow 
Corning) were dispensed along the length of the rotating rod.  By adjusting the rotation speed,   46 
the distance between rod and hotplate, and the hotplate temperature, the thickness of the PDMS 
film that coated the polystyrene rod was controlled.  Following thorough curing of the silicone 
coating,  the  polystyrene  core  was  dissolved  by  immersion  in  acetone  overnight.    Thorough 
rinsing and de-swelling of the silicone in water left a PDMS tube with wall thickness ranging 80-
120μm.  One end of the tube was pinched and sealed with a bolus of fast-cure silicone (KWIK-
SIL, World Precision Instruments), the other end was trimmed to a total tube length of 8.5 cm. 
Artificial spinal tissue was fabricated by pouring warm (≈ 40ﾰC) gelatin solution (10% gelatin by 
weight in water, gelatin from bovine skin, Sigma-Aldrich) into a silicone mold containing a 
cylindrical cavity, 3.2mm in diameter and 10cm long. The mold was then placed in a fridge for 
1h to allow for the gel to set.  The gelatin ‘spinal tissue’ was recovered from the mold and placed 
in  a  desiccator  under  mild  vacuum  for  several  hours.    Partial  loss  of  water  content  caused 
shrinkage and stiffening of the gelatin ‘spinal tissue’. This allowed for its insertion inside the 
surrogate dura mater tube together with a stiff or soft implant.  The assembled model was then 
immersed in water overnight to re-hydrate the hydrogel ‘spinal tissue’ and secure the implant in 
the artificial intrathecal space.  The open end of the model was then sealed with quick setting 
silicone and the model was ready for mechanical tests. 
Verification of the compression modulus of the hydrogel was conducted through an indentation 
test.  A large slab (6cm thickness, 12cm diameter) of gelatin hydrogel was prepared and indented 
with a spherical indenter (6mm diameter) mounted on a mechanical testing platform (Model 42, 
MTS Criterion).  By fitting a Hertz contact model to experimental force versus displacement data 
we obtained a compressive elastic modulus of 9.2±0.6 kPa (n=5 test runs) for the 10% gelatin 
hydrogel.  Indentation of rat spinal cords yields closely comparable values (28).    47 
In vitro electrochemical characterization of e-dura electrodes 
In vitro Electrochemical Impedance Spectroscopy of e-dura electrodes under stretch (Fig. 
3A, 3E, fig. S12) 
We developed an experimental set-up combining electrochemical impedance spectroscopy with 
cyclic mechanical loading.  The e-dura implant under test was mounted in a customized uni-
axial stretcher and immersed in saline solution to conduct electrochemical characterization of the 
electrodes following different stretching protocols. 
Electrochemical Impedance Spectroscopy measurements were conducted in phosphate buffered 
saline (PBS, pH 7.4, Gibco) at room temperature using a three-electrode setup and a potentiostat 
equipped with a frequency response analyzer (Reference 600, Gamry Instruments).  A 5cm long 
Pt  wire  served  as  counter  electrode  and  a  Standard  Calomel  Electrode  (SCE)  as  reference.  
Impedance spectra were taken at the open circuit potential.  The excitation voltage amplitude 
was 7mV.  Impedance spectra of individual electrodes were measured at tensile strains of 0%, 
20% and 45%.  
Stretching in PBS of the e-dura implants was conducted in a LabView-controlled, custom-built 
uniaxial tensile stretcher programmed to actuate two clamps moving in opposite directions along 
a horizontal rail.  Each clamp held a stiff plastic rod pointing downwards from the plane of 
motion.  The lower halves of the rods were submerged in a vessel holding electrolyte.  The 
device under test was attached to the submerged part of the rods with silicone glue (KWIK-SIL, 
World Precision Instruments), so that the motion of the clams was transferred to the device under 
test (Movie S1).  The stretcher was programmed to hold the implant under test at a specific strain 
or to execute a pre-set number of stretch-relaxation cycles (for example 0%-20%-0% at a stretch 
rate of 40%/s).    48 
Cyclic Voltammetry (CV) of electrodes under stretch (Fig. 3B) 
CV responses were recorded in 0.15M H2SO4 (pH 0.9) under N2 purge.  A potential scan rate of 
50mV/s  was  used  within  the  potential  range  of  -0.28V  to  +1.15V  (vs.  SCE).    Due  to  the 
difference in pH, this potential range corresponds to -0.6V to +0.8V (vs. SCE) in PBS.  For each 
tested electrode, 20 priming cycles (1,000mV/s) were applied to allow the electrode to reach a 
steady state.  
 
Charge injection capacity (CIC) of e-dura electrodes (fig. S11, Fig. 3C) 
CIC is a measure of the maximum charge per phase per unit area an electrode coating can deliver 
through  reversible  surface  reactions.    For  CIC  determination,  electrodes  with  the  platinum-
silicone composite coating were immersed in PBS and cathodic-first, biphasic current pulses 
(200μs per phase) were passed between the electrode and a large platinum counter electrode.  A 
pulse stimulator (Model 2100, A-M Systems) delivered the current pulses, and the electrode 
polarization  (vs.  SCE)  was  recorded  on  an  oscilloscope  (DPO  2024  Digital  Phosphor 
Oscilloscope, Tektronix).  The amplitude of the current pulses was gradually increased until the 
electrode under test was polarized just outside the water window (the instantaneous polarization 
of the electrodes due to Ohmic resistances in the circuit was subtracted from voltage traces).   
For experiments where the CIC was determined after cyclic pulse delivery, the repeating pulses 
were charge balanced, biphasic (200μs per phase) with amplitude of 100μA.    
 
In vivo Electrochemical Impedance Spectroscopy of e-dura electrodes (fig. 3E) 
The impedance of e-dura electrodes implanted over lumbosacral segments were recorded using a 
bipolar electrode configuration (working and counter electrode only).  The counter electrode was   49 
a ‘Cooner’ wire whose de-insulated tip was implanted in the osseous body of vertebra L1.  As 
with in vitro measurements, impedance spectra were obtained with a potentiostat equipped with a 
frequency  response  analyzer  (Reference  600,  Gamry  Instruments)  using  the  same  settings.  
Weekly electrochemical impedance spectroscopy measurements of all electrodes were made in 
fully awake rats held by an experienced handler.  
 
Scanning Electron Microscopy of e-dura electrodes (fig. S13) 
Scanning electron microscopy (Zeiss Merlin FE-scanning electrode microscope) was used to 
visualize e-dura electrodes under tensile strain.  Prior to imaging, a 5nm thick layer of platinum 
was sputtered on the implant under investigation.  To image the electrode active sites under 
tensile strain in situ, the e-dura implant was mounted and stretched in a custom-made miniature 
stretcher that can be inserted in the microscope chamber.  
 
Mechanical characterization of the platinum-silicone composite (fig. S2) 
A block of platinum-silicone composite was cut to produce a high aspect-ratio pillar of 3mm 
height and 480µm x 110µm rectangular base.  The sample was glued to a glass slide so that the 
pillar’s long axis was vertical (sticking out of the plane of the glass slide). A miniature force 
probe (FT-S10000 Lateral Microforce Sensing Probe, FemtoTools) applied a force at the tip of 
and normal to the pillar.  Using beam bending theory, the geometry of the beam, and its force-
displacement characteristics, we computed a value for the composite’s Young’s modulus of 10 
MPa. 
   50 
Tensile mechanical properties of rat spinal cord (Fig. 1B) 
A section of rat dura mater was explanted from a 2-month old Lewis rat and cut to a strip with 
dimensions of 3.4mm x 1mm.  Immediately post explantation, each end of the strip was secured 
to a glass cover slip using a fast acting cyanoacrylate adhesive.  The cover slips were inserted 
into the clamps of a tensile testing platform (Model 42, MTS Criterion).  Extension at strain rate 
of 0.5%/s was continuously applied until the dura mater sample failed.  The thickness of the dura 
mater sample was determined from optical micrographs.  During the process of mounting and 
stretching, the dura mater sample was kept hydrated with saline dispensed from a micropipette.  
The stress(strain) response plotted Fig. 1B for spinal tissues was adapted from (27). 
 
Deformation analysis of the spinal cord - implant model (fig. S9) 
The  biomechanical  coupling  of  the  implant  with  the  spinal  cord  depends  on  the  implant’s 
materials and geometry, and the mechanical response of the spinal cord.  
 
Influence of implant bending stiffness  
Bending stiffness is defined by Eq. 1,  
      (1) 
where   and   are Young’s modulus and Poisson’s ratio of the implant material, respectively, 
and    is  the  thickness  of  the  implant.    We  neglected  the  contribution  of  the  thin  metal 
interconnects on the overall implant mechanical behavior.   
If the bending stiffness of the implant is large compared to that of the surrounding tissue, the 
implant cannot accommodate the deformation of the tissue.  In the context of an implant inserted 
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in the intrathecal space, this translates in compression of the spinal tissue.  We used plane strain 
finite element simulation to investigate the effect of bending stiffness of the implant on the 
deformation of spinal tissues and quantified the resulting maximum principal logarithmic strain 
inside the hydrogel ‘spinal tissue’.  When the bending stiffness of the implant is much higher 
than that of dura mater, the implant distorts the spinal tissue.  The lower the bending stiffness, 
the less interference is induced by the implant.  Ideally the bending stiffness of the implant 
should be as low as possible.  In practice, bending stiffness comparable to dura mater may be 
sufficient, as demonstrated with results obtained with the soft e-dura implants. 
 
Influence of tensile stiffness mismatch (fig. S9C) 
Tensile stiffness is defined in Eq. 2: 
      (2) 
with  A,  the  cross-sectional  area  of  the  structure  perpendicular  to  the  tensile/compression 
direction and E, the Young’s modulus of the implant material. 
We define three zones along the length of the spinal cord model: in zone 1, the spinal tissue is 
implant-free, in zone 2, the implant sits above the spinal tissues, and zones 3 depict the transition 
between zones 1 and 2.  
Except for the transition region of the size comparable to the diameter of the spinal cord, the 
strain of the regions 1 and 2 should be homogeneous.  By force balance we will have: 
      (3)  
with ɛ1 and ɛ2 the strain in zone 1 and 2 respectively. 
If the implant is very stiff, then  . As a result,  and the implant will severely limit 
the motion of the spinal tissue.  
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A stiff implant may also result in debonding during stretch.  The debonded implant will slide 
relative  to  the  spinal  cord  and  dura  mater  as  the  animal  moves.    Such  repetitive  relative 
movements may trigger and maintain neuroinflamation in the spinal tissue.  The energy release 
rate G for debonding is expressed in Eq. 4:   
      (4) 
where  is the bonding width of the implant (29). 
When an overall strain   is applied along the spinal cord system, 
      (5)  
Once  the  implant  material  and  geometry  are  selected,  ,   and    can  be  resolved  with 
equations  (3)-(4)-(5).    The  table  below  summarizes  these  parameters  when  the  spinal  cord-
implant  model  is  stretched  by  10%  strain,  and  compares  the  different  coverage  rate  of  the 
implant, characterized by the ratio l1/l, for the soft (PDMS) and stiff (polyimide) implants.  
 
  Soft implant ( )  Stiff implant ( ) 
             
10%  7.6%  10.3%  0.97J/m
2  0.1%  11.0%  4.13 J/m
2 
50%  8.5%  11.5%  1.19 J/m
2  0.2%  18.0%  11 J/m
2 
90%  9.7%  13.1%  1.90 J/m
2  1.0%  50.5%  84.5 J/m
2 
 
A stiff implant severely constraints the motion of the underlying spinal tissues (0.1% <  ɛ1 <1% 
for ɛappl = 10%).  Furthermore, as the coverage rate increases, the strain in zone 2 (outside of the 
implant coverage) is rapidly increasing reaching nearly 50% (for ɛappl = 10%) when the implant 
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covers 90% of the length of the spinal cord.  As the result of this strain concentration, the energy 
release rate for debonding is one order of magnitude higher than a soft e-dura implant made of 
PDMS. 
 
Animal groups and surgical procedures  
All surgical procedures were performed in accordance with Swiss federal legislation and under 
the guidelines established at EPFL.  Local Swiss Veterinary Offices approved all the procedures. 
Experiments were performed on Lewis rats (LEW/ORlj) with initial weight of 180-200g. 
 
Animal groups 
  In the biocompatibility study, rats received either a sham (n=4), stiff (n=4) or soft (n=4) 
implant.  Prior to surgery rats were handled and trained daily in the locomotor tasks for three 
weeks.  These tasks included walking overground along a straight runway, and crossing a 
horizontal ladder with irregularly spaced rungs.  Prior to the training, rats underwent a mild 
food deprivation and were rewarded with yoghurt at the end of each trial.  The body weight 
was monitored closely; in case of weight loss the food deprivation was adjusted.  The animals 
were terminated 6 weeks post-implantation.  
  In the study with electrochemical spinal cord stimulation, rats (n=3) were first implanted with 
an  e-dura  over  lumbosacral  segments,  and  with  bipolar  electrodes  into  ankle  muscles  to 
record electromyographic (EMG) activity.   After 10 days of  recovery  from surgery, they 
received a spinal cord injury.   54 
  Recording of electrospinograms were obtained in a separate group of rats that were implanted 
with an e-dura over lumbosacral segments, and with bipolar electrodes into ankle muscles of 
both legs.  Recordings were obtained after 6 weeks of implantation. 
  Recording of electrocorticograms were obtained in a group of rats (n = 3) that were implanted 
with an e-dura over the leg area of the motor cortex, and with bipolar electrodes into ankle 
muscles  of  both  legs.    These  rats  followed  the  same  behavioral  training  as  rats  in  the 
biocompatibility group. 
  Recording of electrocorticograms following optical stimulation were obtained in Thy1-ChR2-
YFP transgenic mice (Jackson Laboratories, B6.Cg-Tg-(Thy1-COP4/EYFP)18Gfng/J) under 
acute, anesthetized conditions.  
 
Implantation of e-dura into the spinal subdural space (fig. S4A-B) 
The e-dura were implanted under Isoflurane/Dorbene anesthesia.  Under sterile conditions, a 
dorsal midline skin incision was made and the muscles covering the dorsal vertebral column 
were removed.  A partial laminectomy was performed at vertebrae levels L3-L4 and T12-T13 to 
create  entry  and  exit  points  for  the  implant.    To  access  the  intrathecal  space,  a  3mm  long 
mediolateral incision was performed in the dura mater at both laminectomy sites.  A loop of 
surgical suture (Ethilon 4.0) was inserted through the rostral (T12-T13) dura mater incision and 
pushed horizontally along the subdural space until the loop emerged through the caudal (L3-L4) 
dura mater incision.  The extremity of the implant was then folded around the suture loop. The 
loop was then retracted gently to position the implant over the spinal cord.  A small portion of 
the implant protruded beyond the rostral dura mater incision and could be manipulated with fine 
forceps  to  adjust  the  mediolateral  and  rostrocaudal  positioning  of  the  implant.   55 
Electrophysiological  testing  was  performed  intra-operatively  to  fine-tune  positioning  of 
electrodes with respect to lumbar and sacral segments (25).  The protruded extremity of the 
implant became encapsulated within connective tissues, which secured positioning of the implant 
in the chronic stages.  
The soft-to-wires (and microfluidic) connector was secured to the bone using a newly developed 
vertebral orthosis.  The connector was first positioned above the vertebral bone.  Four micro-
screws  (Precision  Stainless  Steel  303  Machine  Screw,  Binding  Head,  Slotted  Drive,  ANSI 
B18.6.3, #000-120, 0.125) were inserted into the bone of rostral and caudal vertebrae. Surgical 
suture (Ethilon 4.0) was used to form a cage around the micro-screws and connector.  The walls 
of the cage were plastered using freshly mixed dental cement (ProBase Cold, Ivoclar Vivadent) 
extruded through a syringe.  After solidification of the dental cement, the electrical wires and 
microfluidic  tube  were  routed  sub-cutaneously  to  the  head  of  the  rat,  where  the  Omnetics 
electrical  connector  and  the  microfluidic  access  port  were  secured  to  the  skull  using  dental 
cement.  The same method was used to create the vertebral orthosis for stiff and sham implants 
in the biocompatibility study.  
 
Implantation of e-dura into the cortical subdural space (fig. S4C-D) 
The e-dura were implanted under Isoflurane/Dorbene anesthesia.  Under sterile conditions, 2 
trepanations were performed on the left half of the skull to create two windows rostral and caudal 
to the leg area of the motor cortex.  The first window was located cranially with respect to the 
coronal suture, while the second window was located cranially with respect to the interparietal 
suture.  Both windows were located close to sagittal suture in order to position the center of the 
e-dura electrodes 1 mm lateral and 1mm caudal relative to the bregma.  The surgical insertion   56 
technique developed for passing e-dura into the spinal subdural space was also used to implant 
e-dura into the cortical subdural space.  Excess PDMS material was cut in the cranial window, 
and the edge of the implants sutured to the dura mater using a Ethilon 8.0 suture.  The exposed 
parts of the brain and external part of the e-dura were covered with surgical silicone (KWIK-
SIL).  A total of 4 screws were implanted into the skull around the e-dura connector before 
covering the entire device, the connector, and the percutaneous amphenol connector with dental 
cement. 
 
Implantation of electrodes to record muscle activity 
All the procedures have been reported previously (25).  Briefly, bipolar intramuscular electrodes 
(AS632;  Cooner  Wire)  were  implanted  into  the  tibialis  anterior  and  medial  gastrocnemius 
muscles,  bilaterally.    Recording  electrodes  were  fabricated  by  removing  a  small  part  (1mm 
notch) of insulation from each wire.  A common ground wire (1cm of Teflon removed at the 
distal  end)  was  inserted  subcutaneously  over  the  right  shoulder.  All  electrode  wires  were 
connected to a percutaneous amphenol connector (Omnetics Connector Corporation) cemented 
to the skull of the rat.  The proper location of EMG electrodes was verified post-mortem. 
 
Spinal cord injury 
Under Isoflurane/Dorbene anesthesia, a dorsal midline skin incision was made from vertebral 
level T5 to L2 and the underlying muscles were removed.  A partial laminectomy was performed 
from around T8 to expose the spinal cord.  The exposed spinal cord was then impacted with a 
metal  probe  with  a  force  of  250  kDyn  (IH-0400  Impactor,  Precision  Systems  and   57 
Instrumentation).  The accuracy of the impact was verified intra-operatively, and all the lesions 
of the animals used in this study were reconstructed post-mortem. 
 
Rehabilitation procedures after spinal cord injury 
Rats with severe contusion spinal cord injury were trained daily for 30min, starting 7 days post-
injury.    The  neurorehabilitation  program  was  conducted  on  a  treadmill  using  a  robotic 
bodyweight support system (Robomedica) that was adjusted to provide optimal assistance during 
bipedal stepping (8, 25).  To enable locomotion of the paralyzed legs, a serotonergic replacement 
therapy combining quipazine (0.03 ml) and 8-OHDPAT (0.02 ml) was administered through the 
microfluidic  channel  of  chronically  implanted  e-dura,  and  tonic  electrical  stimulation  was 
delivered through the electrodes located overlying the midline of lumbar (L2) and sacral (S1) 
segments (40Hz, 0.2ms pulse duration, 50-200µA) (25).  
 
Histology and Morphology of explanted spinal cord  
Fixation and explantation 
At the end of the experimental procedures, rats were perfused with Ringer's solution containing 
100 000 IU/L heparin and 0.25% NaNO2 followed by 4% phosphate buffered paraformaldehyde, 
pH  7.4  containing  5%  sucrose.    The  spinal  cords  were  dissected,  post-fixed  overnight,  and 
transferred to 30% phosphate buffered sucrose for cryoprotection.  After 4 days, the tissue was 
embedded and the entire lumbosacral tract sectioned in a cryostat at a 40µm thickness.  
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3D reconstruction of the spinal cord (Fig. 2B, fig. S6) 
To  assess  spinal  cord  morphology,  a  Nissl  staining  was  performed  on  25  evenly  spaced 
lumbosacral cross-sections separated by 0.8 mm, for each rat.  The slides were assembled into 
the Neurolucida image analysis software (MBF Bioscience, USA) to reconstruct lumbosacral 
segments in 3D.  Spinal cord compression was quantified using a circularity index defined as 4π 
area/perimeter
2.  Circularity index was measured for all the slices, and averaged for each rat to 
obtain a mean value that was compared across groups. 
 
Immunohistochemistry protocols (Fig. 2C, fig. S7) 
Microglial  and astrocytic reactivity  was  revealed by performing  immunohistological  staining 
against glial fibrillary acidic protein (GFAP) and ionized calcium binding adapter molecule 1 
(Iba1), respectively.  Briefly, lumbosacral spinal cord coronal sections were incubated overnight 
in  serum  containing  anti-Iba1  (1:1000,  Abcam,  USA)  or  anti-GFAP  (1:1000,  Dako,  USA) 
antibodies.    Immunoreactions  were  visualized  with  appropriate  secondary  antibodies  labeled 
with  Alexa  fluor®  488  or  555.    A  fluorescent  counterstaining  of  the  Nissl  substance  was 
performed  with  the  Neurotrace  640/660  solution  (1:50,  Invitrogen,  USA).    Sections  were 
mounted onto microscope slides using anti-fade fluorescent mounting medium and covered with 
a  cover-  glass.    The  tissue  sections  were  observed  and  photographed  with  a  laser  confocal 
fluorescence microscope (Leica, Germany). 
 
Immunostaining quantification  
Immunostaining  density  was  measured  offline  using  6  representative  confocal  images  of 
lumbosacral segments per rat.  Images were acquired using standard imaging settings that were   59 
kept constant across rats.  Images were analyzed using custom-written Matlab scripts according 
to previously described methods (8).  Confocal output images were divided into square regions 
of interest (ROI), and densities computed within each ROI as the ratio of traced fibers (amount 
of  pixels)  per  ROI  area.    Files  were  color-filtered  and  binarized  by  means  of  an  intensity 
threshold.  Threshold values were set empirically and maintained across sections, animals and 
groups.  All the analyses were performed blindly. 
 
μ-Computed Tomography 
Spinal cord model (Fig 2D, fig. S9) 
Non-destructive  computed  tomography  (CT)  reconstructions  of  the  spinal  cord  model  were 
obtained with a Skyscan 1076 scanner (Bruker microCT, Kontich, Belgium).  The following 
settings were used: accelerating voltage 40 kV, accelerating current 250 µA, exposure time per 
image 180 ms, angular resolution 0.5°.  The resultant projection images were reconstructed into 
3D renderings of the model using NRecon and GPURecon Server (Bruker microCT, Kontich, 
Belgium).    The  resultant  volumetric  reconstructions  had  a  voxel  size  of  37μm.    This  limit 
prevented the direct visualization of stiff implants, whose thickness was 25μm. 
 
In-vivo implant imaging (Fig. 1F) 
Imaging of implanted e-dura (5 weeks post implantation) was conducted in the same scanner.  
Rats were kept under Isoflurane anesthesia during the scan to reduce motion artifacts.  Scanner 
settings were adjusted to avoid artefacts induced by metallic parts of the spinal orthosis (typical 
settings were: 1 mm aluminum filter, voltage 100 kV, current 100 µA, exposure time 120 ms, 
rotation step 0.5).  Prior to imaging, a contrast agent (Lopamiro 300, Bracco, Switzerland) was   60 
injected through the microfluidic channel of the implants to enable visualization of soft tissues 
and e-dura.  Segmentation and 3D model were constructed with Amira® (FEI Vizualisation 
Sciences Group, Burlington, USA). 
 
Recordings and analysis of muscle activity and whole-body kinematics (Fig. 2, Fig. 
4, fig. S5, fig. S16, fig. S17) 
Bilateral hindlimb kinematics were recorded using 12 infrared motion capture cameras (200 Hz; 
Vicon).  Reflective markers were attached bilaterally overlying iliac crest, greater trochanter 
(hip), lateral condyle (knee), lateral malleolus (ankle), distal end of the fifth metatarsal (limb 
endpoint) and the toe (tip).  Nexus (Vicon) was used to obtain 3D coordinates of the markers.  
The body was modeled as an interconnected chain of rigid segments, and joint angles were 
generated accordingly.  Muscle activity signals (2 kHz) were amplified, filtered (10–1000-Hz 
bandpass) and recorded using the integrated Vicon system.  Concurrent video recordings (200 
Hz) were obtained using two cameras (Basler Vision Technologies) oriented at 90° and 270° 
with respect to the direction of locomotion (8, 25). 
A minimum of 8 gait cycles was extracted for each experimental condition and rat.  A total of 
135 parameters quantifying gait, kinematics, ground reaction force, and muscle activity features 
were computed for each limb and gait cycle according to methods described in detail previously 
(8, 25). These parameters provide a comprehensive quantification of gait patterns ranging from 
general features of locomotion to fine details of limb motion. The entire list of 135 computed 
parameters is described in table S1. 
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Principal component analysis 
The various experimental conditions led to substantial gait changes, which were evident in the 
modification of a large proportion of the computed parameters. In order to extract the relevant 
gait  characteristics  for  each  experimental  condition,  we  implemented  a  multi-step  statistical 
procedure based on principal component (PC) analysis (8, 25). PC analyses were applied on data 
from all individual gait cycles for all the rats together. Data were analyzed using the correlation 
method, which adjusts the mean of the data to zero and the standard deviation to 1. This is a 
conservative  procedure  that  is  appropriate  for  variables  that  differ  in  their  variance  (e.g. 
kinematic vs.  muscle activity data). PC scores  we extracted to  quantify  differences  between 
groups or conditions. Analysis of factor loadings, i.e. correlation between each variable and PC, 
identified the most relevant parameters to explain differences illustrated on each PC.  
 
Acute recordings of electrocorticograms in mice (Fig. 4A) 
Thy1-ChR2-YFP  mice  were  anesthetized  with  Ketamine/Xylasine  and  head-fixed  in  a 
stereotaxic frame (David Kopf Instruments).  A 2x2 mm
2 craniotomy was performed over the leg 
area of the motor cortex, which was verified by the induction of leg movements in response to 
optogenetic stimulation. The e-dura was placed over the exposed motor cortex and covered with 
physiological saline. We employed a diode-pumped solid state blue laser (473 nm, Laserglow 
technologies) coupled via a FC/PC terminal connected to a 200µm core optical fiber (ThorLabs) 
to deliver optical stimulation. Using a micromanipulator, the fiber was placed at the center of 
each  square  formed  by  4  adjacent  electrodes.  Optical  stimulation  was  delivered  through  the 
transparent elastomeric substrate to illuminate the surface of the motor cortex.  A train of light 
pulses  was  delivered  at  4Hz,  9ms  duration,  30mW  intensity  for  each  site  of  stimulation.   62 
Electrocorticograms  were  recorded  using  the  same  methods  as  employed  in  rats.  For  each 
electrode, the amplitude of light-induced electrocorticograms was extracted, normalized to the 
maximum recorded amplitude for that electrode, and the peak to peak amplitude calculated. The 
values measured across all the electrodes were used to generate color-coded neuronal activation 
maps.  
 
Chronic recordings of electrocorticograms in freely behaving rats (Fig. 4B, fig. S14) 
Electrocorticograms  were  measured  in  conjunction  with  whole  body  kinematics  and  muscle 
activity recordings during standing and walking in freely behaving rats (n=3 rats). The rats were 
tested every week for 3 weeks after chronic implantation of the e-dura over the hindlimb area of 
the  motor  cortex.  A  lateral  active  site  integrated  in  the  e-dura  was  used  as  a  reference  for 
differential  amplification.  A  wire  ground  was  fixed  to  the  skull  using  a  metallic  screw. 
Differential recordings were obtained using a TDT RZ2 system (Tucker Davis Technologies), 
amplified with a PZ2 pre-amplifier, sampled at 25 kHz, and digital band-passed filtered (0.1 - 
5000 Hz). Raw electrocorticograms were elaborated using previously described methods (23), 
which  are  summarized  in  fig.  S14.  Kinematic  and  muscle  activity  recordings  were  used  to 
dissociate standing and walking states.  
 
Chronic recordings of electrospinograms (Fig. 4C, fig. S15) 
Recordings of electrical potentials from the electrodes integrated in the chronically implanted e-
dura, which we called electrospinograms, were performed after 6 weeks of implantation (n=3 
rats).    Experiments  were  performed  under  urethane  (1  g/kg,  i.p.)  anesthesia.    Both 
electrospinograms  and  muscle activity  were recorded in  response to  stimulation delivered to   63 
peripheral  nerve  or  motor  cortex.    The  sciatic  nerve  was  exposed,  and  insulated  from  the 
surrounding tissue using a flexible plastic support.  A hook electrode was used to deliver single 
biphasic pulses of increasing amplitude, ranging from 150 to 350 µA, and 100 µs pulse-width, at 
0.5 Hz.  Each trial was composed of at least 30 pulses. Responses measured in  chronically 
implanted  muscles  and  from  each  electrode  integrated  in  the  e-dura,  were  extracted  and 
triggered-averaged. To elicit a descending volley, a custom-made wire electrode was inserted 
overlying  the  leg  area  of  the  motor  cortex,  in  direct  contact  with  the  dura  mater.    Current 
controlled bi-phasic pulses were delivered every minute using a 1mA, 1ms pulse-width stimulus.  
Responses were then extracted, and triggered-averaged. Signals were recorded using a TDT RZ2 
system (Tucker Davis Technologies), amplified with a PZ2 Pre-amplifier, and sampled at 25 kHz 
with a digital band-passed filtered (1 - 5000 Hz).  Electrospinograms were recorded differentially 
from  each  active  site  of  the  implants  with  respect  to  a  reference  fixed  to  one  of  the  bony 
vertebrae.  The latency, amplitude, and amplitude density spectrum of the recorded signals were 
analyzed offline. 
 
Electrochemical stimulation of the spinal cord (Fig. 4E, fig. S16) 
Electrochemical stimulation protocols were selected based on an extensive amount of previous 
studies in rats with spinal cord injury (8, 24, 25). The chemical stimulation used during training 
was administered through the microfluidic channel integrated in the chronically implanted  e-
dura.  After 1-2 minutes, subdural electrical stimulation currents were delivered between active 
electrodes located on the lateral aspect or midline of sacral (S1) and lumbar (L2) segments, and 
an indifferent ground located subcutaneously.  The intensity of electrical spinal cord stimulation 
was  tuned  (40Hz,  20-150μA,  biphasic  rectangular  pulses,  0.2ms  duration)  to  obtain  optimal   64 
stepping visually.  To demonstrate the synergy between chemical and electrical stimulation, we 
tested  rats  without  any  stimulation,  with  chemical  or  electrical  stimulation  alone,  and  with 
concurrent electrochemical stimulation.  To demonstrate the previously inaccessible capacity to 
facilitate  specific  aspects  of  locomotion  with  subdural  electrical  stimulation,  we  delivered 
electrical  stimulation  using  electrodes  located  on  the  lateral  aspects  of  lumbar  and  sacral 
segments, and compared locomotor movements with stimulation delivered bilaterally.  
 
Statistical analysis 
All data are reported as mean values ± S.E.M. or when indicated in the text, as mean values ± 1 
S.D.  Statistical  evaluations  were  performed  using  one-way  analysis  of  variance  (ANOVA), 
paired Student’s t-test, or repeated-measure ANOVA. The Tukey’s multiple comparisons test 
was applied when appropriate. 
 